menu search

Novavax to host conference call to discuss third quarter 2023 financial results and operational highlights on november 9, 2023

GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing pro...

November 2, 2023, 9:25 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...

November 2, 2023, 2:00 am

Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller

Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene expression and ...

October 31, 2023, 11:00 am

Alternative protein global investment leader big idea ventures announces first new protein fund ii singapore cohort

SINGAPORE, Oct. 30, 2023 (GLOBE NEWSWIRE) — Big Idea Ventures, a global leader investing in alternative prot...

October 31, 2023, 1:00 am

Seelos therapeutics to present a poster on sls-005 in alzheimer's disease at neuroscience 2023

-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzhe...

October 27, 2023, 8:11 am

Eisai presents new leqembi® (lecanemab-irmb) investigational subcutaneous formulation interim study results and clinical improvement data in earlier stages of early alzheimer’s disease from additional

Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patien...

October 25, 2023, 9:26 pm

Eisai presents new leqembi® (lecanemab-irmb) investigational subcutaneous formulation interim study results and clinical improvement data in earlier stages of early alzheimer’s disease from additional

Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patien...

October 25, 2023, 9:26 pm

Moderna and caris life sciences partner to develop mrna oncology therapeutics

Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and molecular science firm Caris Life Science...

October 24, 2023, 10:21 am

Galectin therapeutics to participate in the h.c. wainwright 7th annual nash investor conference on october 24, 2023

NORCROSS, Ga., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin...

October 23, 2023, 8:00 am

Tyson, one of the biggest meat producers, is investing in insect protein

Tyson, a major US producer of beef, pork and chicken, is betting on protein that comes from insects....

October 20, 2023, 6:42 am

Tyson foods joins insect protein rush using burger waste

Tyson Foods (NYSE:TSN), one of the US's largest meat processing companies, is to invest in Protix International a specialist in insect ingredients. Th...

October 17, 2023, 10:23 am

Tyson foods partners with insect ingredient maker protix

Tyson Foods Inc. TSN, +1.83% said Tuesday it is planning to acquire a minority stake in Protix, a Dutch company that's a leader in insect ingredients,...

October 17, 2023, 8:12 am

Simply good foods: positioned exceptionally for the nutritional revolution

SMPL's revenue has grown incredibly well, with a CAGR of +12% during the last decade. EBITDA has exceeded this, with a CAGR of +15%. The company has a...

October 16, 2023, 9:35 pm

Inhibikase therapeutics highlights unblinded functional analysis from the 201 trial of risvodetinib in untreated parkinson’s disease and provides update on ongoing enrollment

BOSTON and ATLANTA, Oct. 16, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceu...

October 16, 2023, 11:00 am

Biontech to present multiple program updates across modalities at esmo congress 2023

MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...

October 16, 2023, 3:30 am

Arvinas announces upcoming bavdegalutamide poster presentation at esmo congress 2023

NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...

October 15, 2023, 10:07 pm

Nautilus biotechnology to announce third quarter financial results on october 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule ...

October 11, 2023, 12:05 pm

Nautilus biotechnology to announce third quarter financial results on october 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule ...

October 11, 2023, 8:05 am


Search within

Pages Search Results: